Yoshitsuga Shitaka

Health Technology

Commercial Services

Profile

Yoshitsuga Shitaka is currently the Chief Executive Officer at Agensys, Inc. and the President, Director, and Chief Scientific Officer at Astellas Institute for Regenerative Medicine since 2021.

Yoshitsuga Shitaka active positions

Companies	Position	Start
OCATA THERAPEUTICS INC	President	-
Agensys, Inc. Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA.	Chief Executive Officer	-

All active positions of Yoshitsuga Shitaka

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Yoshitsuga Shitaka's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Astellas Institute for Regenerative Medicine Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA.	Health Technology
Agensys, Inc. Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA.	Commercial Services